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abstract
 
Calmodulin is a ubiquitous Ca
 
2
 
 
 
 binding protein that modulates the in vitro activity of the skeletal
muscle ryanodine receptor (RyR1). Residues 3614–3643 of RyR1 comprise the CaM binding domain and muta-
tions within this region result in a loss of both high-afﬁnity Ca
 
2
 
 
 
-bound calmodulin (CaCaM) and Ca
 
2
 
 
 
-free CaM
(apoCaM) binding (L3624D) or only CaCaM binding (W3620A). To investigate the functional role of CaM bind-
ing to this region of RyR1 in intact skeletal muscle, we compared the ability of RyR1, L3624D, and W3620A to re-
store excitation–contraction (EC) coupling after expression in RyR1-deﬁcient (dyspedic) myotubes. W3620A-
expressing cells responded normally to 10 mM caffeine and 500 
 
 
 
M 4-chloro-
 
m
 
-cresol (4-cmc). Interestingly,
 
L3624D-expressing cells displayed a bimodal response to caffeine, with a large proportion of cells (
 
 
 
44%) show-
ing a greatly attenuated response to caffeine. However, high and low caffeine-responsive L3624D-expressing myo-
tubes exhibited Ca
 
2
 
 
 
 transients of similar magnitude after activation by 4-cmc (500 
 
 
 
M) and electrical stimulation.
Expression of either L3624D or W3620A in dyspedic myotubes restored both L-type Ca
 
2
 
 
 
 currents (retrograde
coupling) and voltage-gated SR Ca
 
2
 
 
 
 release (orthograde coupling) to a similar degree as that observed for wild-
type RyR1, although L-current density was somewhat larger and activated at more hyperpolarized potentials in
W3620A-expressing myotubes. The results indicate that CaM binding to the 3614–3643 region of RyR1 is not es-
sential for voltage sensor activation of RyR1.
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INTRODUCTION
 
Excitation–contraction (EC)* coupling is the process
by which membrane depolarization triggers Ca
 
2
 
 
 
 re-
lease from the sarcoplasmic reticulum (SR), thereby re-
sulting in muscle contraction. In contrast to cardiac EC
coupling where the inﬂux of extracellular Ca
 
2
 
 
 
 triggers
SR Ca
 
2
 
 
 
 release through RyRs (Nabauer et al., 1989),
EC coupling in skeletal muscle does not depend on
Ca
 
2
 
 
 
 inﬂux (Armstrong et al., 1972), but rather relies
on a unique bidirectional mechanical interaction be-
tween dihydropyridine receptors (DHPRs) in the sur-
face membrane and RyRs in the SR (Nakai et al., 1996;
Grabner et al., 1999; Avila and Dirksen, 2000). The
skeletal muscle DHPR is a voltage-gated L-type Ca
 
2
 
 
 
channel (L-channel) that also functions as the voltage
sensor for skeletal-type EC coupling. The skeletal mus-
cle isoform of the ryanodine receptor (RyR1) functions
as a large Ca
 
2
 
 
 
-conducting intracellular Ca
 
2
 
 
 
 release
channel located in the terminal cisternae of the SR. De-
polarization-induced conformational changes in the
skeletal muscle DHPR are transmitted to the release
channel via interactions between the II-III loop of the
 
 
 
1S
 
 subunit of the DHPR (Tanabe et al., 1990) and mul-
tiple cytoplasmic region(s) of RyR1 (Nakai et al., 1998),
which ultimately result in the activation of RyR1 and
the subsequent release of Ca
 
2
 
 
 
 from the SR.
Both the DHPR 
 
 
 
1S
 
 subunit and RyR1 are required
for the EC-coupling process in skeletal muscle; the ab-
sence of either results in a complete loss of both volt-
age-gated SR Ca
 
2
 
 
 
 release and EC coupling. In 
 
 
 
1S
 
-null
(dysgenic) mice, the absence of the voltage sensor pre-
cludes voltage-gated activation of RyR1. Similarly, in
RyR1-knockout (dyspedic) mice, the absence of the SR
Ca
 
2
 
 
 
 release channel eliminates the pathway for Ca
 
2
 
 
 
release from the SR. Interestingly, although dyspedic
myotubes express sarcolemmal voltage sensors, there is
a signiﬁcant reduction in L-type Ca
 
2
 
 
 
 channel function
that is restored after reintroduction of RyR1 (Nakai et
al., 1996). This observation provides strong evidence
for a bidirectional interaction between the DHPR and
RyR1, in which DHPRs not only send an orthograde
signal to RyR1 to trigger SR Ca
 
2
 
 
 
 release, but also re-
ceive a retrograde signal from RyR1 that enhances the
Ca
 
2
 
 
 
-conducting activity of the DHPR (Nakai et al.,
1996; Grabner et al., 1999; Avila and Dirksen, 2000).
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CaM Modulation of EC Coupling
 
Although activation of RyR1 during EC coupling de-
pends on a reciprocal gating interaction with the skel-
etal muscle DHPR, RyR1 proteins also interact with
a diverse group of other regulatory proteins and
small molecules. The RyR1 homotetramer binds four
FKBP12 proteins, one per monomer, and binding of
FKBP12 regulates the proper gating of the release
channel (Jayaraman et al., 1992; Brillantes et al.,
1994). RyR1 also interacts with other proteins such as
triadin, junctin, calsequestrin, and calmodulin (CaM)
as well as small molecules such as Ca
 
2
 
 
 
, Mg
 
2
 
 
 
, and ATP
(for review see MacKrill, 1999). In addition, the 
 
 
 
-sub-
unit of the DHPR also strongly inﬂuences voltage sen-
sor activation of RyR1 (Beurg et al., 1999). All of these
accessory proteins of EC coupling are present within
sarcolemmal–SR junctions, suggesting that the func-
tional unit of EC coupling in skeletal muscle may actu-
ally represent a macromolecular complex composed
of the DHPR, RyR1, and various other modulatory pro-
teins/molecules.
One of these modulatory proteins is the ubiquitous
Ca
 
2
 
 
 
-sensing protein CaM. CaM is a small, highly con-
served calcium-sensing protein that binds to a diverse
group of targets and plays an important role in many
cellular signaling pathways. The protein has a high de-
gree of internal symmetry, containing four EF-hand
Ca
 
2
 
 
 
 binding motifs, two in the NH
 
2
 
-terminal lobe and
two in the COOH-terminal lobe. This structural divi-
sion between the NH
 
2
 
-terminal and COOH-terminal
regions reﬂects a functional division between the two
lobes (Jurado et al., 1999; Saimi and Kung, 2002). The
protein undergoes a conformational change upon
binding Ca
 
2
 
 
 
, exposing hydrophobic pockets in either
lobe that permit effector binding (Jurado et al., 1999).
Most CaM binding proteins bind CaCaM, whereas a
few, including both 
 
 
 
1S
 
 (Pate et al., 2000; Sencer et al.,
2001) and RyR1 (Tripathy et al., 1995; Moore et al.,
1999; Yamaguchi et al., 2001; Samso and Wagenknecht,
2002), are capable of binding both apoCaM and Ca-
CaM. Although the functional importance of CaM
binding to the skeletal muscle DHPR remains to be re-
solved, there has been considerable progress toward
understanding the role of CaM in the modulation of
RyR1 activity.
Each RyR1 tetramer binds four CaM molecules (1
CaM per RyR1 subunit) in both the absence and pres-
ence of Ca
 
2
 
 
 
. Interestingly, apoCaM and CaCaM bind to
overlapping sites between residues 3614–3643 of RyR1
(Moore et al., 1999; Yamaguchi et al., 2001; Samso and
Wagenknecht, 2002). In the absence of CaM, activation
of RyR1 exhibits a bell-shaped dependence on Ca
 
2
 
 
 
,
with micromolar cytosolic concentrations causing acti-
vation and millimolar concentrations of Ca
 
2
 
 
 
 inhibiting
RyR1 activity (Tripathy et al., 1995). Addition of CaM in
the presence of submicromolar Ca
 
2
 
 
 
 causes further acti-
 
vation of RyR1, whereas at micromolar to millimolar
Ca
 
2
 
 
 
, CaM inhibits RyR1 activity (Tripathy et al., 1995;
Rodney et al., 2000). Thus, in in vitro assays, addition of
CaM shifts the Ca
 
2
 
 
 
 sensitivity of RyR1 to lower concen-
trations of Ca
 
2
 
 
 
. Although there is considerable evi-
dence to suggest that CaM exerts a profound modula-
tory effect on isolated RyR1 activity, the prominent role
of CaM in multiple cellular signaling pathways presents
an obstacle to isolating the effect of CaM on EC cou-
pling in intact muscle cells. However, the recent identiﬁ-
cation of two residues within the 3614–3643 region that
disrupt speciﬁc RyR1–CaM interactions provides a valu-
able tool for examining the role of CaM in EC coupling.
Substitution of an alanine residue for W3620 selectively
disrupts the interaction of CaCaM with RyR1, whereas
an aspartate substitution at L3624 disrupts the binding
and regulation by both apoCaM and CaCaM (Yamagu-
chi et al., 2001).
To investigate the impact of apoCaM and CaCaM
binding to RyR1 on EC coupling, we have functionally
characterized the activity of dyspedic myotubes ex-
pressing either wild-type RyR1, W3620A, or L3624D.
Our results indicate that neither apoCaM nor CaCaM
binding to the 3614–3643 region of RyR1 is required
for bidirectional signaling with the skeletal muscle
DHPR. Although neither L3624D nor W3620A elimi-
nated voltage-dependent Ca
 
2
 
 
 
 release, the W3620A
mutation resulted in a signiﬁcant increase in L-chan-
nel conductance and a slight hyperpolarizing shift in
the voltage dependence of activation of L-channel
conductance and SR Ca
 
2
 
 
 
 release. Nevertheless, the
response of W3620A-expressing myotubes to both
caffeine and 4-chloro-
 
m
 
-cresol (4-cmc) was indistin-
guishable from that of wild-type RyR1. Surprisingly, a
signiﬁcant population of myotubes expressing L3624D
(
 
 
 
44%) showed a markedly attenuated response to
caffeine, whereas normal responsiveness to activation
by both 4-cmc and depolarization was retained. The re-
sults indicate that CaM binding to RyR1 is not essential
for voltage-dependent Ca
 
2
 
 
 
 release by RyR1, but does
impact selective ligand activation of the in situ SR Ca
 
2
 
 
 
release channel.
 
MATERIALS AND METHODS
 
Preparation and Microinjection of Dyspedic Myotubes
 
Myotubes were prepared from the skeletal muscle of newborn
normal and dyspedic mice as described previously (Nakai et al.,
1996; Avila and Dirksen, 2000, 2001). L3624D and W3620A were
constructed as described previously (Yamaguchi et al., 2001). Ex-
pression of RyR1, L3624D, and W3620A in individual dyspedic
myotubes was accomplished by microinjection of nuclei with
cDNA encoding CD8 (0.2 
 
 
 
g/
 
 
 
l) and either RyR1, L3624D, or
W3620A (0.5 
 
 
 
g/
 
 
 
l). Expressing myotubes were subsequently
identiﬁed 48–72 h postinjection by incubation with CD8 anti-
body-coated beads (Dynabeads; Dynal ASA). 
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Intracellular Ca
 
2
 
 
 
 Measurements in Intact Myotubes
 
Intracellular Ca
 
2
 
 
 
 was measured in intact (nonpatched) myo-
tubes loaded with the ﬂuorescent Ca
 
2
 
 
 
 indicator Indo-1 AM (Mo-
lecular Probes) as described previously (Avila et al., 2001). Indo-
1–loaded myotubes were excited at 350 nm using a DeltaRam il-
lumination system (Photon Technology, Inc.). Fluorescence
emission at 405 and 485 nm was monitored using a 40
 
 
 
 (1.35
NA) oil immersion objective, collected using a photomultiplier
detection system, and the results presented as the ratio (R) of
F
 
405
 
/F
 
485
 
. Caffeine (10 mM) and 4-chloro-
 
m
 
-cresol (4-cmc, 500
 
 
 
M) were prepared in normal rodent Ringer’s solution (see be-
low) and applied using a rapid perfusion system (Warner Instru-
ments, Inc.) that permits fast, local application of agonist as well
as rapid washout with control solution (Avila et al., 2001). During
each experiment, myotubes were continuously perfused with ei-
ther control or agonist-containing Ringer’s solution. Multiple
myotubes were measured per dish and bulk gravity perfusion
(
 
 
 
10 ml) with control Ringer’s was used to wash the dish be-
tween each measurement. Peak intracellular Ca
 
2
 
 
 
 changes in re-
sponse to agonist application are expressed as 
 
 
 
Ratio (R
 
agonist
 
 
 
 
 
R
 
baseline
 
). For measurements of electrically evoked Ca
 
2
 
 
 
 transients
in intact myotubes, Indo-1 AM–loaded cells were stimulated (8 V
for 20 ms at 0.5 Hz for 30 s) with an extracellular pipette (Avila et
al., 2001). Data were analyzed using FeliX (Photon Technology,
Inc.) and SigmaPlot 2000 (SPSS, Inc.) software packages. Caf-
feine response histograms were ﬁtted according a standard Gaus-
sian equation of the following general form:
 
(1)
 
Simultaneous Measurement of Voltage-gated L-Channel 
Activity and SR Ca
 
2
 
 
 
 Release
 
The whole-cell patch clamp technique was used to simulta-
neously measure voltage-gated L-type Ca
 
2
 
 
 
 currents (L-currents)
and Ca
 
2
 
 
 
 transients in RyR1-, L3624D-, and W3620A-expressing
myotubes. A 1-s prepulse to 
 
 
 
30 mV was used to inactivate Na
 
 
 
channels and T-type Ca
 
2
 
 
 
 channels. L-currents were online leak-
subtracted using 
 
 
 
P/3 delivered from the holding potential
(
 
 
 
80 mV) before each test pulse. Peak currents were normalized
to total cell capacitance (pA/pF), plotted as a function of test po-
tential, and ﬁtted according to:
 
(2)
 
where G
 
max
 
 is the maximal L-channel conductance, V
 
m
 
 is the test
potential, V
 
rev
 
 is the extrapolated reversal potential, V
 
G1/2
 
 is the po-
tential for half-maximal activation of G
 
max
 
, and k
 
G
 
 is a slope factor.
To measure relative changes in voltage-gated SR Ca
 
2
 
 
 
 release
in patch-clamped myotubes, the Ca
 
2
 
 
 
 indicator K
 
5
 
-Fluo-3 (Molec-
ular Probes) was included in the patch pipette internal solution
and allowed to dialyze 
 
 
 
5 min before all recordings. Myotubes
were excited at 488 nm and ﬂuorescence emission at 535 nm was
collected using a photomultiplier system (Photon Technology,
Inc.). Fluorescence traces were analogue ﬁltered (
 
 
 
 
 
 
 
 0.5 ms) be-
fore digitization at 10 kHz and are expressed as 
 
 
 
F/F ([F
 
peak
 
 
 
 
 
F
 
Base
 
]/F
 
Base
 
). Peak ﬂuorescence during each test pulse was plot-
ted as a function of test potential (V
 
m
 
) and ﬁtted according to:
 
(3)
 
where (
 
 
 
F/F)
 
max
 
 is the maximal ﬂuorescence change, VF1/2 is the
potential for half-maximal activation, and kF is a slope factor.
fx () An
e
x µi – () –
2 () 2σi
2 ⁄
σi 2π
------------------------------.
i 1 =
n
∑ =
IG max*V m Vrev – () 1V G1 2 ⁄ Vm – () kG ⁄ [] exp + {} , ⁄ =
∆FF ⁄∆ FF ⁄ () max 1V F1 2 ⁄ Vm – () kF ⁄ [] exp + {} , ⁄ =
Recording Solutions
Intracellular Ca2  changes in Indo-1–loaded myotubes were mea-
sured from myotubes bathed in normal rodent Ringer’s (in
mM): 145 NaCl, 5 KCl, 2 CaCl2, 1 MgCl2, and 10 Hepes, pH 7.4
with NaOH. The internal solution for macroscopic L-current re-
cordings contained (in mM): 145 Cs-aspartate, 0.1 Cs2-EGTA, 1.2
MgCl2, 5 MgATP, 0.2 K5-Fluo-3 (Molecular Probes), and 10
Hepes, pH 7.4 with CsOH. The external solution contained (in
mM): 145 TEACl, 10 CaCl2, 0.003 TTX (Molecular Probes), and
10 HEPES, pH 7.4 with TEA-OH. Unless otherwise indicated, all
chemicals were from Sigma-Aldrich.
RESULTS
Effects of Mutations within the CaM Binding Region of RyR1 
on Agonist-induced SR Ca2  Release
In normal myotubes (derived from skeletal muscle of
phenotypically normal mice and expressing normal
amounts of RyR1 protein), application of 10 mM caf-
feine typically elicited a rapid peak Ca2  release that is
followed by a maintained plateau phase (Fig. 1 A, left).
Less frequently, application of 10 mM caffeine pro-
duced repetitive Ca2  oscillations (Fig. 1 A, right).
RyR1-expressing dyspedic myotubes also displayed both
of these type of responses (Fig. 1 B); however, a larger
proportion of RyR1-expressing dyspedic myotubes ex-
hibited Ca2  oscillations (76%; 98/129). By contrast,
uninjected dyspedic myotubes respond only very weakly,
if at all, to 10 mM caffeine (Fig. 1 C), which likely arises
from variable expression of RyR3 in dyspedic myotubes,
as suggested previously (Takeshima et al., 1994).
[3H]Ryanodine binding and single channel measure-
ments have shown that CaM shifts the Ca2  sensitivity of
RyR1 toward lower concentrations of Ca2  (Tripathy et
al., 1995; Fruen et al., 2000; Rodney et al., 2000). Appli-
cation of 10 mM caffeine to dyspedic myotubes express-
ing W3620A, which binds apoCaM but not CaCaM
(Yamaguchi et al., 2001), resulted in a response identi-
cal in amplitude and proﬁle to that of RyR1, with 83%
(88/106) of W3620A-expressing myotubes exhibiting
Ca2  oscillations (Fig. 1 D, W3620A). Expression of
L3624D, which almost completely abolishes both
apoCaM and CaCaM binding (Yamaguchi et al., 2001),
resulted in an average peak caffeine response that is
signiﬁcantly lower than that observed for RyR1-express-
ing myotubes (Fig. 1 F). However, underlying this de-
crease in the average response are two distinct popula-
tions of L3624D-expressing myotubes: one that re-
sponds to caffeine much like RyR1 (Fig. 1 E, left) and
another that displays a very weak response to 10 mM
caffeine (Fig. 1 E, right). For subsequent analysis, we
have deﬁned a weak caffeine response as any myotube
in which  Ratio was  0.4;   44% (68/153) of all
L3624D-expressing myotubes responded with a  Ratio
 0.4 (Fig. 1 G). In an attempt to more rigorously quan-
tify this observation, we plotted the  Ratio values re-340 CaM Modulation of EC Coupling
corded from a large number of RyR1-, L3624D-, and
W3620A-expressing myotubes as a frequency distribu-
tion (Fig. 2 A). Not surprisingly, data for both RyR1 (n  
129) and W3620A (n   106) are reasonably well de-
scribed by a single Gaussian distribution. However, data
obtained from L3624D-expressing myotubes (n   153)
clearly fall into two distinct populations, one centered
around   Ratio   0.2 and another centered around
 Ratio  0.8 (Fig. 2 A), consistent with the observation
that some L3624D-expressing cells respond similarly to
RyR1, whereas the rest respond only weakly to 10 mM
caffeine. It is unlikely that this difference arises from an
increase in the threshold for caffeine activation, as
application of 30 mM caffeine also failed to elicit a
normal release in L3624D-expressing myotubes that
showed an attenuated response to 10 mM caffeine (un-
published data).
One possible explanation for this observation is that
the L3624D mutation signiﬁcantly impairs expression
and/or assembly of functional RyR1 channels, since the
mean   Ratio of the weakly responsive population of
L3624D-expressing cells is only slightly higher than that
observed for uninjected dyspedic myotubes. We have
previously documented that dyspedic myotubes exhibit
a signiﬁcantly lower resting Ca2  level than RyR1-
expressing myotubes (Avila et al., 2001). Therefore,
resting Ca2  measurements provide a means of verifying
expression of functional SR Ca2  release channels. Fig.
2 B shows resting F405/F485 ratios for dyspedic, RyR1-,
L3624D-, and W3620A-expressing myotubes. In accor-
dance with previous results, reintroduction of RyR1 in-
creases cytosolic Ca2  levels above that found in unin-
jected dyspedic myotubes (resting F405/F485 ratios were
0.46   0.01 and 0.65   0.01 for uninjected [or CD8
sham-injected; Avila et al., 2001] and RyR1-expressing
dyspedic myotubes, respectively). W3620A-expressing
myotubes and both low and high caffeine-responsive
L3624D-expressing myotubes exhibited resting ratios
that were not signiﬁcantly different from that of
RyR1. However, for each expression condition (RyR1-,
W3620A-, and both low and high caffeine-responsive
L3624D-expressing myotubes), resting ratios were sig-
Figure 1. Caffeine response of Indo-1 AM–loaded dyspedic myotubes expressing CaM binding–deﬁcient RyR1 mutants. Caffeine-
induced Ca2  release (10 mM, black bar) for normal myotubes (A), dyspedic myotubes (C), RyR1- (B), W3620A- (D), and L3624D-express-
ing (E) myotubes. Bars, 60 s. (F) Average peak caffeine-induced Ca2  release ( Ratio   Rcaffeine   Rbaseline; where Rcaffeine is the peak ratio
following caffeine application; *, P   0.001). (G) Percentage of RyR1-, L3624D-, and W3620A-expressing myotubes exhibiting a peak caf-
feine–induced Ca2  release with  Ratio  0.4.341 O’Connell et al.
niﬁcantly higher than that of uninjected dyspedic myo-
tubes (Fig. 2 B). These results indicate that functional
Ca2  release channels are expressed in myotubes micro-
injected with cDNA encoding L3624D, regardless of
their response to caffeine.
Another indication of functional release channel ex-
pression in L3624D cDNA-injected myotubes that re-
sponded poorly to caffeine was the presence of sponta-
neous global Ca2  transients (Fig. 2 C) in these cells.
Spontaneous, action potential–evoked global Ca2 
transients such as those depicted in Fig. 2 C are charac-
terized by a rapid rise ( 10 ms) and decay ( 200 ms)
and are generally smaller than caffeine-induced Ca2 
transients. Thus, these rapid global Ca2  release events
likely arise from spontaneous electrical activity that re-
sult in DHPR activation of SR Ca2  release channels.
Additionally, there was no difference in the population
of cells that displayed spontaneous fast transients
among RyR1, L3624D, and W3620A-expressing myo-
tubes (with 11.8%, 8.5%, and 12.4% of RyR1-, W3620A-,
and L3624D-expressing myotubes exhibiting spontane-
ous transients, respectively). Moreover, similar percent-
ages were observed for L3624D-expressing myotubes
that displayed a robust response to caffeine ( Ratio
 0.4; 12.9%) and those that only weakly responded to
caffeine ( Ratio  0.4; 11.8%). By comparison, due to
the absence of RyR1, dyspedic myotubes are incapable
of exhibiting rapid global changes in [Ca2 ]i that is ac-
tivated by spontaneous electrical activity (EC cou-
pling). Thus, the presence of spontaneous global Ca2 
transients in L3624D-expressing myotubes that exhib-
ited a weak caffeine response (i.e.,  Ratio  0.4) pro-
vides further evidence for the expression of functional
release channels in these cells and suggests that the
L3624D mutation may selectively alter caffeine activa-
tion of the SR Ca2  release channel.
To determine whether the decrease in activation by
caffeine in L3624D-expressing cells was speciﬁc for caf-
feine or reﬂects a general loss of pharmacological acti-
vation of the release channel, we also examined the
sensitivity to activation by 4-chloro-m-cresol (4-cmc).
4-cmc is a potent RyR1-selective agonist that, unlike caf-
feine, has no effect on RyR3, presumably because the
site of action for 4-cmc is distinct from that of caffeine
Figure 2. The caffeine response of L3624D-expressing myotubes exhibits a caffeine response distribution. (A) Caffeine response histo-
grams. Data are binned at 0.05  Ratio units and ﬁt according to Eq.1 as described in materials and methods. RyR1- and W3620A-express-
ing myotubes exhibit a single Gaussian distribution (A   5.19,     0.96,     0.38 for RyR1, n   129 and A   6.0,     0.95,     0.48 for
W3620A, n   106). The caffeine response for L3624D-expressing myotubes exhibits a bimodal distribution (A1   2.7,  1   0.16,  1   0.14
and A2   4.4,  2   0.68,  2   0.45 for L3624D, n   153). (B) Resting F405/F485 ratios (*, P   0.001 with respect to dyspedic). (C) RyR1,
W3620A, and both populations of L3624D-expressing myotubes exhibit similar, rapidly activating global intracellular Ca2  transients.342 CaM Modulation of EC Coupling
(Fessenden et al., 2000). Consistent with this observa-
tion, application of 10 mM caffeine elicits a small re-
sponse in dyspedic myotubes while 500  M 4-cmc gen-
erates almost no response (Fig. 3 A, top left). Applica-
tion of 500  M 4-cmc to both RyR1- (Fig. 3 A, top
right) and W3620A-expressing dyspedic myotubes pro-
duces a response that is similar in amplitude to that of
10 mM caffeine (Fig. 3 B). Not surprisingly, application
of 4-cmc to L3624D-expressing myotubes that exhibit a
robust caffeine response also displayed a large response
to 500  M 4-cmc (Fig. 3 A, bottom left). However, 4-cmc
also elicited large Ca2  transients even in L3624D-
expressing myotubes that only weakly responded to 10
mM caffeine (Fig. 3 A, bottom right, and B). Further-
more, repetitive trains of electrical stimulation (8 V for
20 ms at 0.5Hz for 30 s initiated at the arrows in Fig. 3)
evoked Ca2  transients of similar magnitude and kinet-
ics (see insets to Fig. 3 A) in both caffeine-respon-
sive and nonresponsive L3624D-expressing myotubes.
Similar trains of electrically evoked Ca2  transients
were also observed in RyR1-expressing (Fig. 3 A) and
W3620A-expressing myotubes (unpublished data).
Effects of the L3624D and W3620A Mutations on the 
Orthograde and Retrograde Signals of Skeletal 
Muscle EC Coupling
EC coupling in skeletal muscle involves a unique bidi-
rectional signaling interaction between RyR1 and
DHPR proteins, with the DHPR functioning as an acti-
vator of SR Ca2  release (orthograde coupling) and
RyR1 enhancing the Ca2  conducting activity of the
DHPR (retrograde coupling) (Nakai et al., 1996; Grab-
ner et al., 1999; Avila and Dirksen, 2000). To examine
the role of CaM binding to RyR1 on these two cou-
pling mechanisms, we used the whole-cell patch clamp
technique in conjunction with intracellular Ca2  mea-
surements to simultaneously measure voltage-gated
Figure 3. CaM binding–deﬁcient RyR1 mutants
respond normally to both electrical stimulation
and 4-cmc. (A) Representative traces for dys-
pedic, RyR1-, and L3624D-expressing myotubes.
Arrows indicate the beginning of a train of electri-
cal stimuli (30 s, 20-ms pulses of 8 V at 0.5 Hz).
The light gray bars (60 s) deﬁne periods of 10
mM caffeine application and black bars (60 s) de-
ﬁne periods of 500  M 4-cmc application. (In-
sets) The ﬁnal electrically evoked Ca2  transient
from each train is shown on an expanded scale
(scale bars: 0.2  Ratio and 0.2 s shown for RyR1
applies to each inset). (B) Average peak response
to 4-cmc ( Ratio   R4-cmc   Rbaseline, *, P   0.001)
for uninjected dyspedic myotubes, RyR1-express-
ing myotubes, low and high caffeine–responsive
L3624D-expressing myotubes, and W3620A-
expressing myotubes. Number of experiments is
given in parentheses above each bar.343 O’Connell et al.
L-type Ca2  currents and SR Ca2  release from dys-
pedic myotubes expressing either wild-type RyR1,
L3624D, or W3620A. In agreement with previous re-
ports (Nakai et al., 1996; Avila et al., 2001), dyspedic
myotubes did not release Ca2  upon membrane depo-
larization and displayed a very low L-current density
(unpublished data). Reintroduction of RyR1 into dys-
pedic myotubes restored both robust L-channel activ-
ity (retrograde coupling) (Fig. 4 A) and voltage-gated
SR Ca2  release (orthograde coupling) (Fig. 5 A). Ex-
pression of L3624D and W3620A also resulted in resto-
ration of both retrograde and orthograde coupling.
L-channel conductance of L3624D-expressing myo-
tubes was nearly identical in amplitude and voltage de-
pendence to that of RyR1-expressing myotubes (RyR1:
Gmax     202    11 nS/nF, VG1/2    9.7   1.0 mV;
L3624D: Gmax   203   11 nS/nF, VG1/2   10.4   1.4
mV) (Fig. 4 B, Table I). Importantly, all cells posi-
tively identiﬁed as expressing L3624D displayed robust
L-currents and Ca2  transients, suggesting that the fail-
ure of some L3624D-expressing myotubes to fully re-
spond to caffeine does not extend to activation by the
voltage sensor. In contrast to L3624D, myotubes ex-
pressing W3620A exhibited an L-channel current den-
sity that was signiﬁcantly larger (and slightly shifted to
more negative potentials) than that of RyR1-express-
ing myotubes (W3620A: Gmax  270   16 nS/nF, VF1/2  
3.8   2.2 mV).
Figure 4. CaM binding–
deﬁcient RyR1 mutants re-
store voltage-gated L-channel
activity (retrograde coupling)
after expression in dyspedic
myotubes. (A) L-currents elic-
ited in response to 200-ms de-
polarizations to the indicated
potentials for representative
RyR1- (left), L3624D- (mid-
dle), and W3620A-expressing
(right) myotubes. (B) Average
peak I-V relationships for
RyR1-, L3624D-, and W3620A-
expressing myotubes. The lines
through the data represent
Boltzmann ﬁts of the average
data using Eq. 2. For L3624D
and W3620A, a dashed line
representing the ﬁt of the
RyR1 data is also shown for
comparison.
TABLE I
Parameters of I-V and F-V Curves
I-V F-V
n Gmax kV 1/2 Vrev  F/Fmax kV 1/2
nS/nF mV mV mV mV mV
RyR1 27 202   11 5.1   0.2 9.7   1.0 71.8   1.4 4.0   0.5 3.7   0.3 0.1   1.1
L3624D 28 203   11 4.8   0.3 10.4   1.4 74.5   1.5 3.6   0.4 3.7   0.3 1.6   1.4
W3620A 18 270   16a 4.1   0.4 3.8   2.2a 70.4   1.8 3.9   0.6 3.0   0.3  5.9   1.7a
I-V and F-V data are from the number of experiments indicated in column “n”. Parameters are given as mean   SEM and were obtained by fitting each
myotube within a group to the appropriate equation (I-V, Eq. 2 and F-V, Eq. 3). The average cell capacitance for each group was (in pF): 487   29, 397  
22, and 439   42 for RyR1, L3624D, and W3620A, respectively. The average series resistance (Rs, M ) was: 0.9   0.1, 0.9   0.1, and 0.8   0.1 for RyR1,
L3624D, and W3620A, respectively. The average Verror (Rs   Ipeak; mV) was: 3.2   0.4, 3.1   0.3, and 4.0   0.4 for RyR1, L3624D, and W3620A, respectively.
aP   0.01 compared to RyR1.344 CaM Modulation of EC Coupling
Fig. 5 shows that disruption of CaM binding to RyR1
does not alter the magnitude or voltage dependence of
orthograde coupling. Myotubes expressing L3624D dis-
played Ca2  transients that had a peak ﬂuorescence
and voltage dependence not signiﬁcantly different
from that of RyR1 (RyR1:  F/Fmax   4.0   0.5, VF1/2  
0.1   1.1; L3624D:  F/Fmax   3.6   0.4, VF1/2   1.6  
1.4). W3620A-expressing myotubes also had Ca2  tran-
sients of similar magnitude as RyR1-expressing myo-
tubes ( F/Fmax   3.9   0.6, VF1/2    5.9   1.7), al-
though the voltage dependence of these transients was
shifted to approximately the same degree as that ob-
served for L-channel conductance ( 6 mV). Together,
the results of Figs. 4 and 5 indicate that CaM binding to
RyR1 is not required for the targeting or assembly of
functional RyR1 ion channels, their activation by the
DHPR/voltage sensor, or RyR1-mediated enhancement
of DHPR Ca2  channel activity.
DISCUSSION
Evidence has accumulated over the past two decades
that calmodulin is a potent modulator of RyR1 activity
as assessed using a variety of in vitro approaches. Early
studies indicated that the Ca2 -bound form of calmodu-
lin (CaCaM) inhibits RyR1 in the absence of ATP, which
suggested inhibition via a direct interaction rather than
through phosphorylation (Meissner, 1986; Smith et al.,
1989). More recent [3H]ryanodine and single channel
measurements indicate that at low free Ca2  concentra-
tions ( 1   M), apoCaM has a stimulatory effect on
RyR1 channel activity (Tripathy et al., 1995; Fruen et al.,
2000; Rodney et al., 2000). Binding studies show that
apoCaM and CaCaM exert their opposite effects on
RyR1 activity by binding to and dissociating from RyR1
on a time scale of seconds to minutes (Moore et al.,
1999; Yamaguchi et al., 2001). It is therefore likely that
CaM is constitutively bound to the receptor.
In the present study, the role of CaM binding to a
speciﬁc domain of RyR1 (3614–3643) in modulating
EC coupling in intact skeletal myotubes was examined.
Given the extensive biochemical evidence that CaM is a
potent modulator of RyR1 activity, a surprising ﬁnding
was that expression of L3624D or W3620A in dyspedic
myotubes restored EC coupling to an extent nearly in-
distinguishable from that of wild-type RyR1. Both
L3624D and W3620A appeared to form functional re-
lease channels that are correctly targeted to the junc-
tion, based on their ability to restore spontaneous ac-
tion potential-evoked Ca2  release, 4-cmc responsive-
ness, and both orthograde and retrograde coupling
with the DHPR.
Figure 5. CaM binding–deﬁ-
cient RyR1 mutants restore
voltage-gated Ca2  release
(orthograde coupling) after
expression in dyspedic myo-
tubes. (A) Ca2  transients
elicited by 200 ms depolariza-
tion to the indicated poten-
tials for representative RyR1-
(left), L3624D- (middle), and
W3620A-expressing (right)
myotubes. (B) Average peak
F-V relationship for RyR1-,
L3624D-, and W3620A-express-
ing myotubes. The lines
through the data represent
Boltzmann ﬁts to the average
data using Eq. 3. For L3624D
and W3620A, a dashed line
representing the ﬁt of the
RyR1 data is also shown for
comparison.345 O’Connell et al.
Effect of L3624D and W3620A on Ligand Activation 
of RyR1
The most prominent effect of disrupting the RyR1–
CaM interaction in our experiments was an altered caf-
feine response of a subpopulation of L3624D-express-
ing myotubes. There are several possible explanations
for the attenuated caffeine response. First, those cells
that showed an attenuated response to caffeine may
have failed to express a sufﬁcient number of functional
mutant SR Ca2  release channels. However, our data ar-
gue strongly against this explanation. First, low-resting
Ca2  levels of dyspedic myotubes were signiﬁcantly ele-
vated in L3624D-expressing myotubes that showed an
attenuated response to caffeine, indicating that these
myotubes express functional release channels. Second,
spontaneous and electrically evoked global Ca2  re-
lease transients were observed in weakly caffeine-
responsive L3624D-expressing myotubes. Due to their
extremely rapid activation ( 10 ms), these spontane-
ous and evoked transients clearly represent functional
DHPR-RyR1 orthograde coupling. It is unlikely that low
endogenous RyR3 levels play a signiﬁcant role in initi-
ating these Ca2  release events since RyR3 cannot sub-
stitute for RyR1 in EC coupling (Fessenden et al.,
2000). Third, if  40% of myotubes injected with
L3624D cDNA resulted in the expression of nonfunc-
tional channels, we would have expected this to have
also been reﬂected in patch-clamp experiments. How-
ever, all L3624D-expressing myotubes exhibited large
voltage-gated L-currents and SR Ca2  release in our
patch clamp experiments. Finally, SR Ca2  release trig-
gered by 4-chloro-m-cresol was similar for both RyR1-
expressing myotubes and weakly caffeine-responsive
L3624D-expressing myotubes.
Caffeine and 4-cmc act at distinct sites in RyR1 (Fes-
senden et al., 2002), which may explain the discor-
dance between caffeine and 4-cmc responsiveness of
L3624D-expressing myotubes. Although its precise
mechanism of action in intact cells is unclear, caffeine
augments activation of RyR1 by apoCaM (Balshaw et
al., 2001). Therefore, caffeine may be unable to sufﬁ-
ciently activate L3624D mutant release channels in myo-
tubes since the L3624D mutation abolishes apoCaM
binding to RyR1 (Yamaguchi et al., 2001). Caffeine ac-
tivation of SR Ca2  release in a subpopulation of
L3624D-expressing myotubes could be explained by
the presence of higher levels of RyR3 in these myo-
tubes, and that Ca2  release from RyR3 may serve to fa-
cilitate activation of L3624D channels even in the ab-
sence of apoCaM binding. On the other hand, activa-
tion by 4-cmc may not be dependent on the binding of
apoCaM to RyR1, as it likely acts via a different mecha-
nism (Fessenden et al., 2000). This hypothesis could be
tested in future experiments by evaluating the ability of
caffeine to activate SR Ca2  release after expression
L3624D mutant release channels in RyR1/RyR3 double
knockout myotubes.
CaM Binding to the 3614–3643 Region of RyR1 Is not 
Required for Bidirectional DHPR/RyR1 Signaling
Given the postulated role of apoCaM to activate and
CaCaM to inhibit Ca2  release through RyR1, it might
have been expected that disruption of both apoCaM
and CaCaM (L3624D) or only CaCaM (W3620A) bind-
ing to RyR1 would signiﬁcantly affect voltage-gated
Ca2  release during EC coupling. Morphological evi-
dence from freeze-fracture studies has suggested that
in junctional SR, only every other release channel is as-
sociated with a tetrad of DHPRs (Block et al., 1988),
raising the question of how “uncoupled” release chan-
nels are activated and inactivated. One hypothesis is
that Ca2  released from the mechanically coupled ryan-
odine receptors activates and inactivates adjacent, un-
coupled release channels. In such a scenario, CaM may
act to ﬁne-tune the activation of uncoupled release
channels by increasing (apoCaM) and lowering (Ca-
CaM) their intrinsic Ca2  sensitivity. However, maximal
SR Ca2  release in response to depolarization was unaf-
fected by either mutation and in L3624D-expressing
myotubes the voltage dependence of Ca2  release was
identical to that of RyR1. Additionally, no signiﬁcant
difference was seen in either the t1/2 (time to 50%) of
Ca2  transient activation in voltage-clamp experiments
(t1/2 at  50 mV was 24.1   1.9 ms, 22.1   1.8 ms,
and 26.8   2.4 ms for RyR1-, W3620A-, and L3624D-
expressing myotubes, respectively) or the t1/2 of decay of
spontaneous Ca2  transients measured in intact Indo-
1–loaded myotubes (t1/2 was 0.11   0.06 s, 0.11   0.02 s,
and 0.09   0.01 s for RyR1-, W3620A-, and L3624D-
expressing myotubes, respectively). Thus, apoCaM and
CaCaM appear to impart little, if any, impact on SR
Ca2  release triggered by the voltage sensor.
Interestingly, expression of W3620A caused a signiﬁ-
cant increase in maximal L-channel conductance (see
Table I). In fact, this increase in L-channel conduc-
tance likely represents an underestimation of the actual
effect of the W3620A mutation because many of the
W3620A-expressing myotubes patch clamped during
the course of our experiments had to be excluded from
the ﬁnal analysis due to the presence of excessively
large L-currents that resulted in signiﬁcant compro-
mise of the voltage clamp. Since the estimated voltage
error due to series resistance, after compensation, for
the myotubes used in Fig. 5 was only slightly larger for
W3620A-expressing myotubes (see legend to Table I),
the increase in L-channel conductance of W3620A-
expressing myotubes may only partially account for the
small ( 6 mV) hyperpolarizing shift in VG1/2 and VF1/2
values observed in these experiments. There are several
possible mechanisms to explain the increased conduc-346 CaM Modulation of EC Coupling
tance through L-channels in W3620A-expressing dys-
pedic myotubes. The W3620A mutation in RyR1 may
promote DHPR subunit synthesis and/or membrane
insertion, thus resulting in an increase in L-channel
surface expression. Alternatively, a conformational
change in RyR1 caused by the W3620A mutation could
alter the efﬁciency of retrograde coupling between
RyR1 and DHPR. In any event, the increase in L-chan-
nel activity is apparently speciﬁc for the W3620A muta-
tion, since L-currents from L3624D-expressing myo-
tubes were identical to that of RyR1.
The results presented here do not entirely exclude a
role for CaM in SR Ca2  release during skeletal mus-
cle EC coupling. First of all, CaM regulation of RyR1
may have long-term or more subtle effects that are not
detected under the experimental conditions used
here. Furthermore, we used single amino acid muta-
tions to disrupt RyR1–CaM interaction that eliminate
high-afﬁnity [35S]CaM binding in in vitro assays
(Yamaguchi et al., 2001). While these mutations were
effective in those assays, it is possible that because of
interactions with the DHPR and/or other accessory
proteins, the mutant release channels adopt a confor-
mation that permits CaM binding when expressed
within junctions of intact muscle cells. Another, how-
ever unlikely, possibility is that native RyR1 interac-
tions with other cellular protein(s) unmask a CaM
binding site that is not detected in in vitro assays. In
addition, although EC coupling in cultured myotubes
is widely used as a model for skeletal muscle EC cou-
pling, it is possible that CaM–RyR1 interactions are
developmentally regulated such that CaM–RyR1 bind-
ing is more prevalent in mature skeletal muscle. Fi-
nally, although the experiments in Fig. 3 A indicate
that voltage-gated SR Ca2  release elicited by low fre-
quency (0.5 Hz) repetitive stimulation is similar for
RyR1 and the CaM binding–deﬁcient mutants, it will
be important for future experiments to determine
whether CaM modulates Ca2  release during rapid or
tetanic stimulation.
In conclusion, our results illustrate the importance of
studying the function of EC coupling proteins operat-
ing within an intact muscle cell environment. Voltage-
dependent conformational changes in the DHPR/L-
type Ca2  channel, and not Ca2  or ligand activation
paradigms, are the physiologically relevant trigger for
skeletal muscle EC coupling. Although biochemical
studies provide valuable insights into the function of
proteins of EC coupling, their impact on bidirectional
DHPR–RyR1 functional coupling have yet to be readily
reconstituted in any heterologous expression system.
Our results indicate that under the experimental con-
ditions used here, the control of RyR1 gating by the
skeletal muscle voltage sensor is stronger than any pos-
sible modulatory effects of CaM.
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